Skip to main content
Gates Open Research logoLink to Gates Open Research
. 2023 Nov 20;6:74. Originally published 2022 Jul 1. [Version 2] doi: 10.12688/gatesopenres.13644.2

Regional clustering and waves patterns due to COVID-19 by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants in Peru

Melissa Toyama 1, Lucía Vargas 2, Sofía Ticliahuanca 2, Antonio M Quispe 3,a
PMCID: PMC10692151  PMID: 38045771

Version Changes

Revised. Amendments from Version 1

We have corrected several typos and introduced the following text to highlight the highest mortality rates: At the regional level, we observed that during the first waves, the three regions with the highest mortality overall were Callao (750 deaths per 100,000 inhabitants), Lima (750 deaths per 100,000 inhabitants), and Moquegua (681 deaths per 100,000 inhabitants). During the second wave, the regions with the highest mortality overall were Ica (1035 deaths per 100,000 inhabitants), Arequipa (927 deaths per 100,000 inhabitants), and Lima (894 deaths per 100,000 inhabitants). And during the third wave, the regions with the highest mortality overall were Madre de Dios (395 deaths per 100,000 inhabitants), Ica (349 deaths per 100,000 inhabitants), and Arequipa (341 deaths per 100,000 inhabitants). Also, we revised the description of our clustering analysis as follows: Finally, we characterized the pattern of each regional wave and performed a K-means clustering analysis to assess typical patterns during Peru's first, second, and third waves separately, using the regional weekly mortality as the study outcome. During the K-means clustering analysis, we used the elbow method to determine how many clusters minimized the intra-cluster variance and maximized the inter-cluster variance. And, to confirm the findings of this analysis, we used the silhouette method, which measures the quality of clustering by calculating the average silhouette, which was used to graphically identify the optimal number of clusters by plotting the highest value of the average silhouettes. Finally, we have specified the study's limitations to highlight that the analysis was restricted to mortality data rather than COVID-19 case incidence. Specifically, we have introduced the following sentence at the end of our discussion: "This is important because the analysis in our study was restricted to mortality data rather than COVID-19 case incidence."

Abstract

Background

Coronavirus disease 2019 (COVID-19) impact varies substantially due to various factors, so it is critical to characterize its main differences to inform decision-makers about where to focus their interventions and differentiate mitigation strategies. Up to this date, little is known about the patterns and regional clustering of COVID-19 waves worldwide.

Methods

We assessed the patterns and regional clustering of COVID-19 waves in Peru by using the weekly mortality rates for each of the 25 regions as an outcome of interest. We obtained the death counts from the National Informatics System of Deaths and population estimates from the National Registry of Identification and Civil Status. In addition, we characterized each wave according to its duration, peak, and mortality rates by age group and gender. Additionally, we used polynomial regression models to compare them graphically and performed a cluster analysis to identify regional patterns.

Results

We estimated the average mortality rate at the first, second, and third waves at 13.01, 14.12, and 9.82 per 100,000 inhabitants, respectively, with higher mortality rates among elders and men. The patterns of each wave varied substantially in terms of duration, peak, impact, and wave shapes. Based on our clustering analysis, during the first wave caused by the index virus, the 25 regions of Peru presented six different wave patterns. However, the regions were clustered in two different wave patterns during the second and third, caused by alpha/lambda/delta and omicron.

Conclusions

The propagation of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) variants behaved in Peru with varying wave patterns and regional clustering. During the COVID-19 pandemic, the weekly mortality rates followed different spatiotemporal patterns with solid clustering, which might help project the impact of future waves of COVID-19.

Keywords: COVID-19, SARS-CoV-2, mortality, epidemiology, cluster analysis, Peru

Introduction

Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019 1 and spread rapidly throughout the world. Its arrival in Latin America was registered on February 26, 2020, in Brazil 2 , and the first case in Peru was confirmed just nine days later, on March 6 3 . Peru became one of the first Latin American countries to implement quarantine and other restrictive measures; however, the spread of the index virus did not stop across Peru 4 . One year later, Peru accumulated over 210,000 deaths due to COVID-19, leading the list of countries with the highest mortality rates worldwide in the first and second waves 5 .

Peru has registered three COVID-19 waves, dominated primarily by the index virus and the lambda/gamma, and delta/omicron SARS-CoV-2 variants, respectively 6 . During these waves, some regions suffered waves of catastrophic magnitudes, such as the first wave of the region of Loreto, with the capital city of Iquitos 7 reporting the highest seroprevalence worldwide in July 2020 8 . Peru reported the beginning of the second wave in November 2020, which soon became the deadliest wave in Latin America again, mainly because of the rapid spread of the gamma and lambda variants 9 , and the many lessons not learned during its first wave 10 . The third wave in Peru started slowly, with record case numbers increasing explosively in January 2022, reaching a peak over five times higher than the peak observed at the second wave. The third wave was characterized by the initial predominance of delta and the explosive increase of cases due to the introduction of omicron BA.1, but had significantly lower mortality than previous waves.

Now that the third wave is currently ending in Latin America, it is crucial to collect the many lessons learned from this experience to inform the decision-making in future waves. Like many low-middle-income countries, Peru has health systems with inequalities that disproportionately impact its different regions and provinces 11 . Certainly, we can take many lessons from previous waves and further understand how COVID-19 spread across countries’ regions. This information may help adapt public health interventions, maximize their impact, and adjust to their common regional characteristics 12 and different demographics 13 . Unfortunately, very little has been described in the literature on this critical subject. This study seeks to fill this scientific knowledge gap by assessing the all-cause mortality per epidemiological week as the outcome of interest, since it has been reported consistently as the most reliable tracer of the impact of the COVID-19 pandemic in low-middle-income countries 14 . Thus, we analyzed the weekly mortality rate to characterize each of the three COVID-19 waves that affected Peru at the regional level and assessed their patterns and regional clustering.

Methods

Study design and population

We conducted a cross-sectional study to characterize and compare the first, second, and third waves of COVID-19 in each region of Peru. Peru’s territory encompassed 25 regions (“departamentos”), which are subdivided into 196 provinces (“provincias”) and 1,869 districts (“distritos”). For this study, we grouped all the provinces of Lima as the Lima region and included the constitutional province of Callao as an independent region. Consequently, we used the same classification of regions used by the study data sources in our analysis.

Study outcome and data sources

We used the weekly mortality rate as the study outcome. At the national and regional levels, we calculated the weekly mortality rate by multiplying the accumulated death counts per epidemiological week by 100,000 and dividing the product by the estimated annual population. We obtained the death counts, population estimates, variants distributions, and region's geographical boundaries using open data curated from the government of Peru. We described the metadata and links from each of these sources in Table 1. We obtained the death counts from all causes from the National System of Deaths (SINADEF), which is updated daily at the Unique National Health Information Repository (REUNIS) 15 . We obtained the annual estimated population at the regional and national level from the National Institute of Statistics and Informatics (INEI) 16 , registering Peruvian citizens and accurately allocating their residence region. We obtained the weekly distribution of SARS-CoV-2 variants circulating in Peru from the Peruvian National Institute of Health (INS) 17 . Finally, we got the map shapefiles from the Peruvian Ministry of the Environment (MINAM) 18 .

Table 1. Metadata for the datasets used in the research article.

Name Provider Year Format Variable Source
Peruvian
Population 2021
National Institute
of Statistics and
Informatics (INEI)
2021 Comma-
separated
values (CSV)
Continuous https://www.datosabiertos.gob.pe/dataset/
poblaci%C3%B3n-peru
National Deaths
Informatics System
(SINADEF)
Ministry of Health
(MINSA)
2022 Comma-
separated
values (CSV)
Continuous https://www.datosabiertos.gob.pe/dataset/
informaci%C3%B3n-de-fallecidos-del-sistema-
inform%C3%A1tico-nacional-de-defunciones-sinadef-
ministerio
Genomic sequencing
of the SARS-CoV-2
virus in Peru
National Institute
of Health (INS)
2022 Power Bi
Dashboard
Continuous https://web.ins.gob.pe/es/covid19/secuenciamiento-
sars-cov2
Peru regional
boundaries
Ministry of the
Environment
(MINAM)
2007 Shapefile Continuous https://geoservidorperu.minam.gob.pe/geoservidor/
archivos/download/Limite_departamental.rar

Legend: The "Format" column indicates the extension of the data. The "Variable" column reports the variable type of the data. Finally, the "Source" column presents the links to each of the datasets used in our study.

Statistical analysis

We performed a descriptive analysis to characterize the COVID-19 waves by calculating the weekly mortality rates at the national and regional levels. We used the epidemiological week in which the Peruvian Ministry of Health confirmed the first COVID-19 death to set the beginning of each first wave, and the end of the third wave as the point at which the weekly mortality rate returned to pre-pandemic levels. We performed a graphical analysis of the weekly mortality rates at the national and regional levels by using the “ggplot2” package 19 . We fit a segmented regression model with unknown break-points to assess the end of the first and second waves, which we defined as the point where the trend in the weekly mortality rates changed from negative to positive. For this purpose, we used the methodology developed by Muggeo VM 20 and the package "segmented" designed by the same author. Next, we calculated and described the mortality variability between women and men and among the age groups of 0 to 19, 20 to 59, and 60 years old and older to assess whether the demographics affected the comparability of the mortality among regions. After this verification, we compared the unstandardized mortalities instead of the standardized mortalities adjusted by age and gender. To compare the duration of each wave, we quantified the "time from the beginning to the peak" and the "total duration" of each wave, both in epidemiological weeks. Also, we compared the peak of each wave (measured as the higher weekly mortality rate), the wave onset week, and the wave last week, which we tabulated as a heat map. Finally, we characterized the pattern of each regional wave and performed a K-means clustering analysis to assess typical patterns during Peru's first, second, and third waves separately using the regional weekly mortality as the study outcome. During the K-means clustering analysis, we used the elbow method to determine how many clusters minimized the intra-cluster variance and maximized the inter-cluster variance. And, to confirm the findings of this analysis, we used the silhouette method, which measures the quality of clustering by calculating the average silhouette, which was used to graphically identify the optimal number of clusters by plotting the highest value of the average silhouettes. We used R 3.6.1 (R Foundation for Statistical Computing, Vienna, Austria) and R Studio 1.2.5001 (Free Software Foundation, Inc., Boston, MA) for the statistical analysis and the QGIS program 3.22 to elaborate the maps with the clustering analysis results.

Results

Duration of the first, second, and third COVID-19 waves in Peru

The Ministry of Health confirmed the first death by COVID-19 at the epidemiological week 10 of 2020, and up to the epidemiological 13-2022, Peru suffered three COVID-19 waves ( Figure 1A). Based on our segmented regression analysis ( Figure 1B), this first wave most likely lasted 39 weeks ending at the epidemiological week 48 of 2020, which consequently was the epidemiological week with the lowest weekly mortality rate before the second wave started. On the other hand, we found that the second wave was the deathlier and the longest among the three waves, with 41 weeks from the epidemiological week 49-2020 until the epidemiological 36-2021. The end of the second wave coincides with the epidemiological week in which delta became the predominant SARS-CoV-2 variant in Peru, representing over 50% of them ( Figure 2). However, the weekly mortality rate increment was minimal until it became explosive when omicron displaced delta and became the predominant variant in the epidemiological week 52-2022. Regardless, the third wave was the less deathly and the shortest one, with an overall duration of 29 weeks from the epidemiological week 37-2021 to the 13-2022. Consequently, the epidemiological week 13-2022 was when the weekly mortality rates returned to pre-pandemic levels.

Figure 1. Evolution of the COVID-19 weekly mortality rates* during Peru's first, second, and third COVID-19 waves.

Figure 1.

The figure shows the evolution of the weekly mortality deaths (death counts per week /100,000 inhabitants of Peru) along the pandemic in Peru ( Figure 1A) contrasted with the baseline mortality pre-pandemic (continuous yellow line) and the beginning epidemiological week of the first, second, and third COVID-19 waves in Peru (red dot lines). Also, it shows the trends estimated in our segmented regression analysis (continuous red line), which we used to determine when each wave started ( Figure 1B).

Figure 2. SARS-CoV-2 variants percentages distribution by epidemiological week during Peru's first, second, and third waves of COVID-19.

Figure 2.

Weekly mortality rates are expressed in death counts per week /100,000 inhabitants of Peru.

Mortality during the first, second, and third COVID-19 waves in Peru

In the first three waves of the COVID-19 pandemic and for 109 weeks, Peru accumulated 514,006 deaths from all causes. Given that the pandemic started in the 10th epidemiological week and the first epidemiological week included the last three days of 2019, we calculated the weekly baseline mortality before the first wave as the mean mortality per week during epidemiological weeks two to nine, which was 7.21 ± 0.22 deaths per 100,000 people. Consequently, we calculated the excess deaths during the first three waves as 258,106 deaths, including 88,273 in the first wave, 145,401 in the second wave, and 24,432 in the third one. Based on these counts, we calculated that the excess deaths represented 49%, 60%, and 26% of all the deaths in the first, second, and third waves, respectively. On the contrary, we observed that the mortality ratio between the adults 60 years old and older and the adults 20 to 59 years-old progressed from 13.1 to 13.4 and 16.2 in the first, second, and third waves. Overall, the second wave was deathlier than the first one, and the first wave was deathlier than the third one ( Table 2).

Table 2. National mortality variability during the COVID-19 pandemic in Peru.

Deaths counts Mortality
1st Wave 2nd Wave 3rd Wave 1st Wave 2nd Wave 3rd Wave
Total deaths 180 014 241 551 92 441 553.45 742.64 284.21
Excess deaths 88 273 145 401 24 432
By gender
  Women 70 337 103 703 43 207 427.97 647.59 269.81
  Men 109 677 137 848 49 234 677.40 834.81 298.16
By age groups
  0 to 19 y. o. 5658 8553 5263 53.43 74.65 45.94
  20 to 59 y. o. 43 249 64 079 20 808 241.68 364.07 118.22
  60 or over y. o. 131 022 168 864 66 370 3164.45 4869.22 1913.36

Legend: Mortality is expressed in death counts per wave/100,000 inhabitants of Peru.

Variability of the mortality rate across regions by wave, age, and gender

Overall, at the national level, higher mortality was recorded during the second wave (743 deaths per 100,000 inhabitants), followed by the first wave (553 deaths per 100,000 inhabitants) and the third wave (284 deaths/per 100,000 inhabitants). At the regional level, we observed that during the first waves, the three regions with the highest mortality overall were Callao (750 deaths per 100,000 inhabitants), Lima (750 deaths per 100,000 inhabitants), and Moquegua (681 deaths per 100,000 inhabitants). During the second wave, the regions with the highest mortality overall were Ica (1035 deaths per 100,000 inhabitants), Arequipa (927 deaths per 100,000 inhabitants), and Lima (894 deaths per 100,000 inhabitants). And during the third wave, the regions with the highest mortality overall were Madre de Dios (395 deaths per 100,000 inhabitants), Ica (349 deaths per 100,000 inhabitants), and Arequipa (341 deaths per 100,000 inhabitants). Furthermore, we observed high variability of the weekly mortality weeks among waves and, within each wave, across regions ( Figure 3). Nevertheless, it was consistently higher among men than women and adults 60 years old and older compared to other age groups ( Table 3). At the regional level, we observed that during the first, second, and third waves, the mortality rate among men was higher than among women in all regions except for Arequipa during the third wave. Likewise, the mortality among the people 60 years old and older was higher than those aged 20 to 59 years old and 0 to 19 years old in all three waves, with the elders' age group consistently having the highest mortality rates. During the first wave, the region of Huancavelica had the most increased mortality among people 60 years old and older, with 4,413 deaths per 100,000 inhabitants. During the second wave, Ica was the region with a higher mortality rate, with 6,131 deaths per 100,000 inhabitants. And during the third wave, Huancavelica was again the region with a higher mortality rate, with 2,673 deaths per 100,000 inhabitants. Madre de Dios had a higher mortality rate among the people 20 to 59 years old age group, with 361 deaths per 100,000 inhabitants during the first wave. During the second wave, Ica registered the higher mortality, with 544 deaths per 100,000 inhabitants, and during the third wave, Madre de Dios reported the higher mortality, with 313 deaths per 100,000 inhabitants. Among people in the 0 to 19 years old age group, Madre de Dios had the higher mortality rate during the first, second, and third wave, with 161,226, and 161 deaths per 100,000 inhabitants, respectively.

Figure 3. Heat map of the weekly mortality rates by region during Peru's first, second, and third waves of COVID-19.

Figure 3.

Weekly mortality rates are expressed in death counts per week /100,000 inhabitants of Peru.

Table 3. Regional mortality variability by age and gender during COVID-19 pandemic in Peru.

Region Total mortality Female mortality Male mortality Female/male mortality ratio 0 to 19 years old mortality 20 to 59 years old mortality 60 years old and older mortality
W1 W2 W3 W1 W2 W3 W1 W2 W3 W1 W2 W3 W1 W2 W3 W1 W2 W3 W1 W2 W3
Callao 750 852 311 551 772 290 960 1013 331 0.57 0.76 0.88 47 60 34 324 444 128 3505 5056 1840
Lima 701 894 305 518 785 298 898 1003 311 0.58 0.78 0.96 50 56 32 281 424 112 3373 5327 1926
Moquegua 681 720 305 510 582 267 830 870 344 0.61 0.67 0.78 30 86 40 256 315 101 3467 4122 1873
Ica 676 1035 349 532 904 332 819 1168 365 0.65 0.77 0.91 43 80 48 319 544 146 4083 6131 2173
Arequipa 651 927 341 498 823 337 809 1035 344 0.62 0.80 0.98 48 82 48 242 445 134 3533 5325 2033
Ancash 605 852 328 489 743 303 719 960 352 0.68 0.77 0.86 66 89 52 233 371 128 3588 5682 2197
Tumbes 586 730 300 497 568 248 663 897 352 0.75 0.63 0.70 65 113 59 285 357 132 3624 5584 2336
Huancavelica 535 601 265 503 576 264 566 632 265 0.89 0.91 1.00 99 90 51 253 309 116 4413 5987 2673
La Libertad 523 734 306 411 658 291 636 807 319 0.65 0.82 0.91 54 79 52 220 344 127 3014 4859 2044
Madre de Dios 513 695 395 373 476 250 621 945 556 0.60 0.50 0.45 161 226 161 361 534 313 2784 4725 2393
Junín 512 789 299 422 682 279 602 897 318 0.70 0.76 0.88 75 84 51 239 406 127 3268 5696 2212
Piura 472 679 290 363 594 260 580 762 319 0.63 0.78 0.82 39 77 53 212 337 125 3007 4728 2045
Puno 461 670 310 381 579 289 543 757 330 0.70 0.76 0.88 71 85 44 219 330 131 2753 4826 2327
Cusco 447 718 298 391 639 288 502 796 308 0.78 0.80 0.94 78 113 61 204 337 133 3033 4701 1932
Ucayali 431 588 283 346 483 263 509 686 304 0.68 0.70 0.87 61 110 81 253 340 164 3111 4022 1857
Huánuco 423 568 254 378 491 242 466 644 267 0.81 0.76 0.91 61 85 57 201 270 119 3544 4345 1871
Apurímac 399 736 314 385 669 297 412 809 331 0.93 0.83 0.90 59 86 52 160 318 136 3064 5827 2401
Tacna 397 622 240 291 485 215 501 753 265 0.58 0.64 0.81 39 60 29 180 335 100 2096 4078 1729
San Martín 385 543 256 303 452 227 459 644 286 0.66 0.70 0.79 49 95 57 216 287 132 2850 4317 1980
Loreto 372 397 185 282 340 166 455 457 204 0.62 0.74 0.81 56 101 64 240 261 113 2835 2903 1311
Lambayeque 357 412 137 236 335 122 485 466 152 0.49 0.72 0.8 16 33 26 176 222 63 1884 2281 793
Pasco 349 522 229 312 446 221 384 605 236 0.81 0.74 0.94 85 67 55 185 309 112 2255 4274 1893
Ayacucho 292 565 264 260 533 262 322 599 266 0.81 0.89 0.98 47 87 54 131 264 112 2220 4853 2267
Cajamarca 284 460 203 232 418 193 336 498 213 0.69 0.84 0.91 36 68 44 128 209 83 2229 3510 1551
Amazonas 210 279 110 163 242 109 254 311 111 0.64 0.78 0.98 33 58 35 113 152 50 1700 1972 799

Legend: Mortality is expressed as the total death counts from all causes per 100,000 inhabitants; W1, wave 1; W2, wave 2; W3, wave 3.

Regional cluster analysis

In our cluster analysis, we observed that the spread of COVID-19 across the regions of Peru followed different wave patterns ( Figure 4) in both mortality ( Table 4) and duration ( Table 5). We found six clusters of regions with varying wave patterns in the first wave, either by using the Elbow method ( Figure 4A) or the Silhouette method ( Figure 4B). During the first wave, the regions of Lima and Callao had two of the deathlier and early waves, both beginning in epidemiological week 10. In contrast, Moquegua was the region with the latest onset with a first wave that started at the epidemiological week 16. During the second wave, we characterized two clusters with different region wave patterns ( Figure 4C and Figure 4D). As for the third wave, we also found that the regions of Peru could be classified into two different clusters ( Figure 4E and Figure 4F).

Figure 4.

Figure 4.

Elbow ( A) and Silhouette ( B) analysis according to the weekly mortality rate during the first, second, and third waves of COVID-19 in Peru. Elbow ( A) and Silhouette ( B) clustering analysis during the first wave; Elbow ( C) and Silhouette ( D) clustering analysis during the second wave; and Elbow ( E) and Silhouette ( F) clustering analysis during the first wave.

Table 4. Mortality during the first, second, and third wave in Peru.

Region Basal
weekly
mortality
Cumulative mortality Wave excess deaths Peak´s weekly mortality Clusters
Wave 1 Wave 2 Wave 3 Wave 1 Wave 2 Wave 3 Wave 1 Wave 2 Wave 3 Wave 1 Wave 2 Wave 3
Callao 7.50 697 867 238 427 492 66 40 37 15 1 1 1
Lima 7.25 692 919 141 395 520 47 29 34 15 1 1 1
Ica 8.75 657 1005 229 307 568 63 31 40 19 1 1 1
Ancash 8.88 545 712 361 226 375 59 24 38 16 1 1 1
Tumbes 8.88 518 741 213 216 262 44 40 33 19 1 1 1
Arequipa 8.75 630 902 211 280 465 54 43 39 17 3 1 1
La Libertad 7.38 470 655 282 205 331 76 29 31 14 3 1 1
Junín 8.38 473 784 197 155 349 38 26 27 13 5 1 1
Piura 6.38 409 655 236 186 336 83 30 31 15 2 2 1
Ucayali 7.50 402 558 194 110 183 44 39 29 23 2 2 1
Madre de Dios 9.25 484 728 185 123 210 65 32 35 23 3 2 1
Huánuco 7.88 402 503 195 87 157 14 19 22 12 4 2 1
Apurímac 7.00 341 569 363 96 324 111 15 28 14 4 2 1
San Martín 6.38 329 470 249 106 190 58 23 21 11 4 2 1
Ayacucho 5.75 229 629 124 34 273 49 13 20 13 4 2 1
Cusco 9.00 441 739 136 72 244 19 26 23 13 5 2 1
Huancavelica 9.63 427 657 171 129 118 -12 25 23 13 5 2 1
Puno 8.38 390 639 271 105 237 53 35 21 21 5 2 1
Tacna 6.63 341 629 136 122 251 37 37 31 16 5 2 1
Moquegua 7.50 589 650 281 372 305 71 78 32 17 6 2 1
Loreto 4.75 359 262 226 164 120 46 36 19 12 2 2 2
Lambayeque 6.75 312 407 82 89 9 -26 23 23 8 2 2 2
Pasco 7.25 283 437 241 44 147 2 16 19 11 4 2 2
Cajamarca 5.38 245 434 150 57 165 32 16 19 10 4 2 2
Amazonas 4.25 178 240 74 25 45 -20 12 10 5 4 2 2

Legend: Mortality is expressed as the total death counts from all causes per 100,000 inhabitants.

Table 5. Duration of the first, second, and third wave in Peru.

Region Start (epidemiological week) End (epidemiological week) Time to peak (weeks) Duration (weeks) Clusters
Wave 1 Wave 2 Wave 3 Wave 1 Wave 2 Wave 3 Wave 1 Wave 2 Wave 3 Wave 1 Wave 2 Wave 3 Wave 1 Wave 2 Wave 3
Callao 10 46 43 45 42 12 11 14 13 36 50 23 1 1 1
Lima 10 51 53 50 52 12 12 9 2 41 55 13 1 1 1
Ica 10 50 47 49 46 11 14 9 10 40 50 19 1 1 1
Ancash 11 47 32 46 31 13 13 21 25 36 38 34 1 1 1
Tumbes 12 46 47 45 46 13 11 20 8 34 54 19 1 1 1
Arequipa 11 51 48 50 47 12 20 25 9 40 50 18 3 1 1
La Libertad 11 47 38 46 37 13 14 21 18 36 44 28 3 1 1
Junín 10 48 47 47 46 13 21 10 9 38 52 19 5 1 1
Piura 10 45 42 44 41 12 11 23 14 35 50 24 2 2 1
Ucayali 10 49 46 48 45 11 9 18 7 39 50 20 2 2 1
Madre de Dios 11 50 53 49 52 13 17 15 2 39 56 13 3 2 1
Huánuco 12 52 43 51 42 13 17 5 13 40 44 23 4 2 1
Apurímac 13 48 30 47 29 13 26 23 28 35 35 36 4 2 1
San Martín 10 45 36 44 35 12 15 24 17 35 44 30 4 2 1
Ayacucho 10 44 53 43 52 12 24 21 3 34 62 13 4 2 1
Cusco 10 51 53 50 52 13 24 16 3 41 55 13 5 2 1
Huancavelica 13 44 47 43 46 13 20 24 9 31 56 19 5 2 1
Puno 11 45 40 44 39 13 22 14 17 34 48 26 5 2 1
Tacna 12 45 49 44 48 11 21 13 8 33 57 15 5 2 1
Moquegua 16 45 38 44 37 12 16 12 19 29 46 28 6 2 1
Loreto 10 51 28 50 27 12 12 9 24 41 30 38 2 2 2
Lambayeque 10 43 49 42 48 12 10 25 8 33 59 16 2 2 2
Pasco 13 46 33 45 32 11 16 10 20 33 40 33 4 2 2
Cajamarca 12 47 44 46 43 13 18 22 13 35 50 22 4 2 2
Amazonas 12 48 41 47 40 10 17 22 7 36 46 22 4 2 2

Legend: Mortality is expressed as the total death counts from all causes per 100,000 inhabitants.

Regional patterns during the first wave caused by the index virus

The first wave of Peru started in Lima, the region that reported the first COVID-19 cases and the first COVID-19 death in the country. Lima showed a similar wave pattern to its surrounding regions, including Ancash in the North, Callao in the East, and Ica in the South. Another region that showed a similar wave pattern to Lima was Tumbes on the northern border of Peru, frontier with Ecuador, which implies that COVID-19 cases may also have entered Peru from Ecuador at the beginning of its first wave ( Figure 5A). During the first wave, the regions of Peru exhibited six different wave patterns ( Figure 6). Overall, all the regions from "cluster one" exhibited a first wave characterized as the earliest and longer lasting, with a mortality rate that did not exceed 40 deaths per 100,000 inhabitants. The first wave spread from Tumbes to Piura, Piura to Lambayeque by the Panamericana highway, and from Lima to Loreto and Ucayali by air traffic. All from "cluster two," these regions exhibited an early and short duration first wave, with a peak weekly mortality rate of 39 deaths per 100,000 inhabitants. Then, the first wave seems to have spread to the nearby regions, including Arequipa from Ica, La Libertad from Ancash, and Madre de Dios from Ucayali. All the regions from "cluster three" exhibited a short duration and intermediate first wave, with a maximum mortality rate of 43 deaths per 100,000 inhabitants. Then, the first wave moved to the highlands, impacting the regions of Amazonas, Apurímac, Ayacucho, Cajamarca, Huánuco, Pasco, and San Martín. The "cluster four" showed a moderate first wave with peaks that did not exceed a mortality rate of 23 deaths per 100,000 inhabitants. Finally, the first wave spread to the southern regions of Peru, impacting the regions of Cusco, Huancavelica, Junín, Puno, and Tacna; all these regions from cluster three had the latest and shorter first waves, with a maximum mortality rate of 37 deaths per 100,000 inhabitants. Among the southern regions of Peru, Moquegua behaves as a stand-alone cluster (cluster six). Despite having one of the latest first waves, Moquegua had the higher peak among all the regions of Peru, with a weekly mortality rate of 78 deaths per 100,000 inhabitants. Moquegua's peak during the first wave was also the highest across all regions and the three waves.

Figure 5. Regional clustering according to the weekly mortality rate during Peru's first, second, and third waves of COVID-19.

Figure 5.

Clusters of regions based on the weekly mortality rates (death counts per week /100,000 inhabitants) during the first ( A), second ( B), and third ( C) waves of COVID-19 in Peru.

Figure 6. Regional wave patterns of the weekly mortality rate during the first wave of COVID-19 in Peru.

Figure 6.

Mortality is expressed as the total death counts from all causes per 100,000 inhabitants.

Regional patterns during the second wave, a wave that shifted from alpha to lambda and gamma predominance

During the second wave, the regions of Peru exhibited two different wave patterns ( Figure 5B and Figure 7). The first cluster was composed by the regions of Ancash, Arequipa, Callao, Ica, Junín, La Libertad, Lima, and Tumbes. During the second wave, these regions had deathlier second waves with higher weekly mortality rates (peak mortality range: 27 to 40 deaths per 100,000 inhabitants). Callao and Ancash had the earliest onset (epidemiological weeks 46 and 47 of 2020, respectively) and Ica the deathlier second wave, with a peak of 40 deaths per 100,000 inhabitants. The second cluster included the regions of Amazonas, Apurimac, Ayacucho, Cajamarca, Cusco, Huancavelica, Huánuco, Lambayeque, Loreto, Madre de Dios, Moquegua, Pasco, Piura, Puno, San Martin, Tacna, and Ucayali. Overall, this cluster had some regions with the faster peak second waves (Pasco, Tacna, Loreto Huánuco, and Moquegua, all with a time to peak below 10 weeks) and some regions with the lower mortality (Amazonas, Pasco, Loreto, and Cajamarca, all with mortalities at the wave peak bellow 20 deaths per 100,000 inhabitants).

Figure 7. Regional wave patterns of the weekly mortality rate during the second wave of COVID-19 in Peru.

Figure 7.

Mortality is expressed as the total death counts from all causes per 100,000 inhabitants.

Regional patterns during the third wave, a wave that shifted from delta to omicron predominance

The third wave started when delta became the most predominant variant in Peru. However, during the third wave, omicron displaced delta and spread violently across the country, starting in most regions simultaneously. Overall, we differentiate two wave patterns ( Figure 5C and Figure 8). The first cluster included all the regions from the coast of Peru except for Lambayeque and Cajamarca, and all the regions with highlands, except for Pasco, plus the southern regions of the jungle Ucayali and Madre de Dios. Among them, Arequipa, Ancash, and Ucayali were the regions with the faster peak (4, 5, and 5 weeks, respectively); Ancash, Huánuco, La Libertad, and Tumbes were the regions with the longest waves (23, 20, 20, and 20 weeks of durations, respectively). At the same time, Madre de Dios, Ucayali, and Puno were the regions with the higher peak mortality (23, 23, and 21 deaths per 100,000 inhabitants at the wave peak, respectively). The second cluster included the regions of Amazonas, Cajamarca, Lambayeque, Loreto, Pasco, and San Martín. These waves were significantly less mortal than cluster one (mean peak mortality: 9.5 ± 2.8 vs. 16.2 ± 3.5 deaths per 100,000 inhabitants; p <0.05).

Figure 8. Regional wave patterns of the weekly mortality rate during the third wave of COVID-19 in Peru.

Figure 8.

Mortality is expressed as the total death counts from all causes per 100,000 inhabitants.

Geographical distribution and statistical correlation between wave clusters

Geographically speaking, the spread of COVID-19 during each of Peru's waves had Lima as the epidemic epicenter and followed the coastal roads (trough the Panamericana highway) to spread to the nearby regions. During the first wave, the epidemic was reported as exported from Lima to Iquitos by over 100 Chinese tourists that traveled early in the wave, including the first case confirmed in Iquitos city 21 . On the other side, pretty much all the regions along the Andes had the latest first waves in the country ( Figure 5A). However, with the introduction of more transmissible and infectious variants, such as alpha, gamma, and lambda, the second wave spread from the coastal regions to the highlands and jungle at once ( Figure 5B). Finally, the introduction of delta started the third wave, which spread violently with the introduction of omicron across the country, and only a few regions of the eastern jungle and northern highlands had late waves ( Figure 5C). Statistically, the first and second wave's clusters distribution correlates significantly (Spearman rho = 0.5468; p = 0.0047), but the second and third wave's clusters do not (Spearman rho = 0.3430; p = 0.0932).

Discussion

The propagation of SARS-COV-2 variants in Peru followed different wave patterns that could be clustered in two to six wave patterns. Since the COVID-19 pandemic started in December 2019 to March 2022, Peru has been hit by three pandemic waves with different mortality rates, wave patterns, and regional clustering. The first wave was caused mainly by the index virus and spread across the 25 regions of Peru with six different wave patterns. The first wave started almost in parallel in Lima and Tumbes, supporting the hypothesis of two entry points of COVID-19 cases in Peru. Comparatively, the mortality during the first wave was nearly as high as the mortality reached during the second wave, being two of the deathlier first and second waves worldwide. The second wave was caused predominantly by the alpha and lambda variants, which were more contagious than the index virus. Both waves were substantially deathlier than the third wave, which was sparked by delta and then exploded with the predominance of omicron. The patterns of each wave varied considerably in terms of duration, peak mortality, overall mortality, and wave shapes. Still, we could identify six, two, and two different clusters of regional wave patterns during the first, second, and third waves, respectively. However, we observed some correlation between the first and second waves, which impacted the coast first and the highlands last. On the contrary, the third wave spread violently across the country, only recently hitting the remote regions of Peru with significantly lower mortality.

The Peruvian government reported ending its second wave of COVID-19 with 200,000 COVID-19 deaths 22 ; however, a recent statistical analysis estimated that by that time, Peru had accumulated around 301,000 COVID-19 deaths (95% confidence interval: 217,000–420,000) and estimated mortality of 885.6 deaths per 100,000 population (95% CI: 639.2–1234.9) 23 . Furthermore, based on these estimates, by the end of the second wave, the COVID-19 prevalence was around 71.8%, which implied that Peru was nearly triple the prevalence estimated at the peak of the first wave (25.2%, CI95%: 22.5%–28.2%) 24 . In our study, we calculated that during the first three waves of the COVID-19 pandemic, Peru accumulated nearly a half-million deaths from all causes and 258,106 excess deaths. We believe that all the excess deaths registered at SINADEF during the first three waves were secondary to COVID-19. The primary evidence to support that hypothesis is the perfect match between the baseline mortality and the lower weekly mortality rates after the first and third waves. This was initially observed by the Prospective Task Force ("Prospectiva"), a group of experts convened by the Peruvian government to advise and provide analytic information to the government authorities. The task force made such a hypothesis during the first wave after quantifying the excess deaths in Peru for the first time, and after, the hypothesis was validated by other government working groups during the second and third waves 25, 26 .

The third wave in Peru seems to have started much earlier than previously reported by the Peruvian Ministry of Health 27 . Based on our segmented regression analysis, which is a novel mathematical solution to the problem of assessing break-points in continuous data distributions 20 , the third COVID-19 wave in Peru started in the epidemiological week 37-2021. This start date is plausible because it is the same epidemiological week where the deathlier variant delta became predominant in Peru when it surpassed the 50% threshold in the distribution of SARS-CoV-2 variants circulating in Peru (as shown in Figure 2). Also, it is plausible that the successful Peruvian COVID-19 immunization campaign mitigated the impact of delta. For context purposes, Peru started vaccinating their first-line workers and the adults 60 years old and older in February 2021, then included their high-risk adults, and then expanded the program to all adults 18 years old or over as the target population 28 . Transition President Sagasti passed the torch to President Castillo in June 2021, with 13% of the target population covered with two doses. Soon after, in preparation for a third wave, Peru decided to accelerate the immunization campaign and set the immunization program goal to cover at least 80% of the adult population with two doses by December 2021 29 . To do so, Peru deployed a massive communication campaign named “I put my shoulder for Peru” (“Pongo el Hombro por el Perú”), tripled the program budget to multiply their vaccinator's brigades, and implemented the home-delivered vaccination strategy called “Let’s meet you” (“Vamos a tu encuentro”) with a territorial and community approach focused on targeting the neighborhoods with the lower vaccination coverage rates 30 . Therefore, it is possible that, despite the predominance of delta, Peru controlled its impact by accelerating its COVID-19 immunization campaign and progressively achieving its programmatic goal of a 50% coverage in October 2021 31 and 80% in December 2021 32 , before omicron became the predominant variant (as shown in Figure 2).

Another important observation from our study is that the third wave not only registered a substantially reduced mortality compared to previous waves, but also registered a substantial reduction in the fraction that excess deaths represent from the total death count from all causes, compared to the first and second wave (47% vs. 60% and 65%, respectively). Furthermore, we also observed an increased mortality ratio among adults 60 years old and older and the mortality among adults 20- to 59-year-old in the third wave relative to the first and second wave (to 16.9 from 13.1 to 13.4, respectively). These results add to the evidence that highlights the impact of COVID-19 vaccination in reducing COVID-19 mortality, but at the same time the increased mortality due to non-COVID-19 causes in the latest months. With most efforts focused on responding to the COVID-19 pandemic, low-middle income countries like Peru have neglected their resources to prevent common non-COVID-19 causes of death, such as those caused by cancer or other preexisting chronic diseases. Scientists from the US 33 , Germany 34 and Italy 35 reported increased mortality in older people during the pandemic and underlying conditions such as heart, kidney, liver, and lung chronic diseases, diabetes, hypertension, dementia, and immunological diseases with and without COVID-19. Hence, in a scenario where the effect of the vaccine reduces COVID-19 mortality, it is expected that non-COVID-19 causes of death became the leading causes of death if it is true that most of the excess deaths were, in fact, secondary to COVID-19 in Peru.

In context, Peru shifted from a first wave caused by the ancestor variant, with a basic reproductive number estimated for the country as 2.97 and in Lima, the capital and only megacity of Peru, as 2.88 36 . This means that the average number of infected contacts per infected individual was close to three, but more importantly three contacts without previous exposure to SARS-CoV-2. Hence, COVID-19 spread quickly across urban areas, hitting clustered cities like Iquitos hardly, where 70% of its total population got COVID-19 with a considerable cost in lives 8 . Then, Peru faced its most deathly wave caused by different and more contagious SARS-CoV-2 variants, including lambda, gamma, and delta, with anecdotic cases of alpha and mu 37 . In the timeline, during the second wave, the SARS-CoV-2 variants predominance shifted from Lambda predominance, which competed with gamma and displaced the ancestor variant completely 38 , towards delta predominance, which was first reported downhill in the second wave and along its end completely displaced Lambda and the other SARS-CoV-2 variants prior. In the third wave, omicron violently spread across the country, completely displacing delta in one month, starting and predominating along with the whole wave.

The key strength of our study is that we analyzed big data from a very reliable death registration system and contrasted three very different COVID-19 waves with a good sense of which SARS-CoV-2 variants dominated each wave. Furthermore, the study might be overpowered because the high mortality observed across each wave allowed us to characterize each pattern properly. Another critical observation that allowed us to simplify the interpretation of our results was the homogenous population in terms of age groups and gender, which allowed us to avoid the need to use standardized mortalities, which was our original intention. We took advantage of this license to simplify our analysis and communicate our results in the same terms as commonly reported by the Peruvian government. However, it is essential to highlight that although the regional populations seem comparable in age groups and gender distribution, there is a crucial variability in rurality, poverty, sanitation, race, altitude, and population density that requires further analysis. Additionally, it is essential to mention that although SINADEF is described as reliable, the register was four years old in 2020 and had 75% real-time data entry, with a remaining 25% having a two to four weeks digitalization delay 39 . Also, it is possible that SINADEF sub-registers the deaths at the peak of each wave due to personal shortages and unregistered burials, particularly in the rural areas. This is important because the analysis in our study was restricted to mortality data rather than COVID-19 case incidence.

Conclusion

Based on the results, we can affirm that Peru's first, second, and third COVID-19 waves were substantially different at the national and regional levels. These differences were more noticeable in the first wave, which showed six different wave patterns with distinct beginnings, mortality rates, mortality peaks, and duration. Although it proved to be deathlier, the second wave was more homogeneous than the first wave. The third wave, on the contrary, was the shortest and less mortal wave, with a homogeneous but certainly more explosive spread than the second wave. The cluster analysis showed that the second and third waves at the regional level could be grouped into two large groups with different mortality peaks. Likewise, it is necessary to mention that the geographical factor would also be a possible explanation for the behavior of the epidemiological waves because neighboring regions were consistently grouped in the same groups. We consider that future research should address this topic in greater depth.

Acknowledgements

With Dr. Quispe as her scientific advisor, Dr. Toyama planned this study as her thesis for her master's in public health at the Universidad Nacional Mayor de San Marcos. We thank the Ministry of Health of Peru for their diligent work updating the SINADEF registry, which was vital for our study. We also acknowledge the professors of the master's in public health for their input and feedback.

Funding Statement

The author(s) declared that no grants were involved in supporting this work.

[version 2; peer review: 2 approved]

Data availability

The data used in our study is open data curated by the Peruvian government and freely available from ( Table 1):

The official administrative boundaries for Peru regions are owned by the Ministry of Environment and can be accessed through the website https://www.geogpsperu.com.

References

  • 1. Flores López MG, Soto Tarazona A, De La Cruz-Vargas JA: Regional distribution of COVID-19 mortality in Peru. Revista de la Facultad de Medicina Humana. 2021;21(2):326–34. 10.25176/RFMH.v21i2.3721 [DOI] [Google Scholar]
  • 2. Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, et al. : COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Med Infect Dis. 2020;35:101613. 10.1016/j.tmaid.2020.101613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Schwalb A, Seas C: The COVID-19 Pandemic in Peru: What Went Wrong? Am J Trop Med Hyg. 2021;104(4):1176–8. 10.4269/ajtmh.20-1323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Hernandez-Vasquez A, Azanedo D: COVID-19 in Peru: the need to pay attention to the high number of police deaths due to the pandemic. J Public Health (Oxf). 2020;42(3):640–1. 10.1093/pubmed/fdaa079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Lossio J: [Covid-19 in Peru: state and social responses]. Hist Cienc Saude Manguinhos. 2021;28(2):581–5. 10.1590/S0104-59702021005000001 [DOI] [PubMed] [Google Scholar]
  • 6. [Genomic sequencing of the SARS-CoV-2 virus in Peru]. Lima, Peru: Instituto Nacional de Salud;2022. [Google Scholar]
  • 7. Fraser B: COVID-19 strains remote regions of Peru. Lancet. 2020;395(10238):1684. 10.1016/S0140-6736(20)31236-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Alvarez-Antonio C, Meza-Sanchez G, Calampa C, et al. : Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study. Lancet Glob Health. 2021;9(7):e925–e31. 10.1016/S2214-109X(21)00173-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Vences MA, Pareja-Ramos JJ, Otero P, et al. : Factors associated with mortality in patients hospitalized with COVID-19: A prospective cohort in a Peruvian national referral hospital. Medwave. 2021;21(6):e8231. 10.5867/medwave.2021.06.8231 [DOI] [PubMed] [Google Scholar]
  • 10. Herrera-Anazco P, Uyen-Cateriano A, Mezones-Holguin E, et al. : Some lessons that Peru did not learn before the second wave of COVID-19. Int J Health Plann Manage. 2021;36(3):995–8. 10.1002/hpm.3135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Hernandez-Vasquez A, Barrenechea-Pulache A, Azanedo D: COVID-19 testing in Peru: low access and inequalities. J Public Health (Oxf). 2021;43(3):e504–e6. 10.1093/pubmed/fdab125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Dahal S, Luo R, Swahn MH, et al. : Geospatial Variability in Excess Death Rates during the COVID-19 Pandemic in Mexico: Examining Socio Demographic, Climate and Population Health Characteristics. Int J Infect Dis. 2021;113:347–54. 10.1016/j.ijid.2021.10.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Ramirez-Soto MC, Ortega-Caceres G, Arroyo-Hernandez H: Excess all-cause deaths stratified by sex and age in Peru: a time series analysis during the COVID-19 pandemic. BMJ Open. 2022;12(3):e057056. 10.1136/bmjopen-2021-057056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Karlinsky A, Kobak D: Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset. eLife. 2021;10:e69336. 10.7554/eLife.69336 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. [National Deaths Informatics System] (SINADEF). Lima, Peru: Ministerio de Salud (MINSA). Reference Source [Google Scholar]
  • 16. [Peruvian Population 2021]. Lima, Peru: Insituto Nacional de Esadística e Informática (INEI). [Google Scholar]
  • 17. [Genomic sequencing of the SARS-CoV-2 virus in Peru]. Lima, Peru: Instituto Nacional de Salud (INS). [Google Scholar]
  • 18. [Peru regional boundaries]. Lima, Peru: Ministerio del Ambiente (MINAM). [Google Scholar]
  • 19. Wickham H: ggplot2: Create elegant data visualisations using the grammar of graphics. New York, U.S.A.: Springer-Verlag;2016. Reference Source [Google Scholar]
  • 20. Muggeo VMR: Estimating regression models with unknown break-points. Stat Med. 2003;22(19):3055–71. 10.1002/sim.1545 [DOI] [PubMed] [Google Scholar]
  • 21. [Loreto’ Health Directorate confirms the first case of the new coronavirus in Iquitos].RPP. 03/17/2020. [Google Scholar]
  • 22. [Minsa: Peru exceeded the barrier of 200,000 deaths from covid-19].El Peruano,2021; 04/18/2021. [Google Scholar]
  • 23. COVID-19 Cumulative Infection Collaborators: Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet. 2022;S0140-6736(22)00484-6. 10.1016/S0140-6736(22)00484-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Reyes-Vega MF, Soto-Cabezas MG, Cárdenas F, et al. : SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru. EClinicalMedicine. 2021;34:100801. 10.1016/j.eclinm.2021.100801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. [Report on the causes of the high number of deaths from the COVID-19 pandemic in Peru].Lima, Peru: Consejo Nacional de Ciencia, Tecnología e Innovación (CONCYTEC);2021. [Google Scholar]
  • 26. [Technical criteria to update the number of deaths from COVID-19 in Peru].Lima, Peru: Ministerio de Salud (MINSA);2021. [Google Scholar]
  • 27. [Press Release 11/01/2022: Minsa confirms third wave due to increase in cases of contagion by COVID-19].Lima, Peru: Ministry of Health of Peru;2022. [Google Scholar]
  • 28. [Ministerial Resolution No. 488-2021-MINSA: Updated National Vaccination Plan against COVID-19].Lima, Peru: Peruvian Ministry of Health;2021. [Google Scholar]
  • 29. [Cevallos: we must accelerate vaccination because the third wave is a very concrete possibility].El Peruano. 09/11/2021. [Google Scholar]
  • 30. Press release 09/07/2021: [Minsa launches strategy 'Let's meet you, get vaccinated now!' to close gaps in vaccination against COVID-19].Lima, Peru: Peruvian Ministry of Health. [Google Scholar]
  • 31. [Press release 10/17/2021: Peru exceeds 14 million vaccinated with two doses, more than 50% of the target population vaccinated against COVID-19].Lima, Peru: Ministry of Health of Peru;2021. [Google Scholar]
  • 32. [Minsa closes the year with 80.04% of the target population vaccinated with two doses against COVID-19].Lima, Peru: Ministry of Health of Peru;2021. [Google Scholar]
  • 33. Cronin CJ, Evans WN: Excess mortality from COVID and non-COVID causes in minority populations. Proc Natl Acad Sci U S A. 2021;118(39):e2101386118. 10.1073/pnas.2101386118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Lampl BMJ, Lang M, Jochem C, et al. : COVID or not COVID: attributing and reporting cause of death in a community cohort. Public Health. 2022;205:157–63. 10.1016/j.puhe.2022.02.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Bartolomeo N, Giotta M, Trerotoli P: In-Hospital Mortality in Non-COVID-19-Related Diseases before and during the Pandemic: A Regional Retrospective Study. Int J Environ Res Public Health. 2021;18(20):10886. 10.3390/ijerph182010886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Torres-Roman JS, Kobiak IC, Valcarcel B, et al. : The reproductive number R0 of COVID-19 in Peru: An opportunity for effective changes. Travel Med Infect Dis. 2020;37:101689. 10.1016/j.tmaid.2020.101689 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Romero PE, Davila-Barclay A, Salvatierra G, et al. : The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America. Microbiol Spectr. 2021;9(2):e0078921. 10.1128/Spectrum.00789-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Vargas-Herrera N, Araujo-Castillo RV, Mestanza O, et al. : SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence. Lancet Reg Health Am. 2022;6:100112. 10.1016/j.lana.2021.100112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Vargas-Herrera J, Ruiz KP, Nunez GG, et al. : [Preliminary results of the strengthening of the national death registry information system]. Rev Peru Med Exp Salud Publica. 2018;35(3):505–14. 10.17843/rpmesp.2018.353.3913 [DOI] [PubMed] [Google Scholar]
Gates Open Res. 2023 Dec 1. doi: 10.21956/gatesopenres.16482.r35520

Reviewer response for version 2

Gerardo Santos-Lopez 1

The authors have corrected the article. I have no further comments to make.

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Yes

Are the conclusions drawn adequately supported by the results?

Yes

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

Diagnosis and epidemiology of viral infections, viral pathogenesis and development of antivirals.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Gates Open Res. 2023 Nov 23. doi: 10.21956/gatesopenres.16482.r35521

Reviewer response for version 2

Anne Bozack 1

I thank the authors for their response to the reviewers' comments and edits to the manuscript. The authors have sufficiently addressed my comments.

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Yes

Are the conclusions drawn adequately supported by the results?

Yes

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

Environmental health science and molecular epidemiology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Gates Open Res. 2023 Nov 8. doi: 10.21956/gatesopenres.14925.r35208

Reviewer response for version 1

Anne Bozack 1

Overall, this manuscript provides a comprehensive and straight-forward analysis of the COVID-19 pandemic in Peru based on temporal mortality waves and regional clustering. This study contributes to better understanding the origin and progression of the pandemic in the country. Below, I note sections that would benefit from additional details as well as several typos that should be corrected.

  • Statistical methods: I believe the elbow and silhouette plots are based on K-means clustering. The authors should specify this as well as which variables are included in the cluster analysis. 

  • Results, first section: "37-2022 to the 13-2022" should be "37-202 1 to the 13-2022".

  • Results, first section: I believe the word "coincidently" is not being accurately used in this context, since the authors define the division of waves and pandemic period based on the points of lowest mortality. I suggest using the word "consequently" instead.

  • Discussion: In the study's limitations, the authors should note that the analysis was restricted to mortality data, rather than looking and Covid incidence. 

  • Results, geographical distribution: " p = 0047" is missing a decimal point.

  • Figure 2: The legend is not correct.

  • Figure 4: "(E)" needs to be reformatted.

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Yes

Are the conclusions drawn adequately supported by the results?

Yes

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

Environmental health science and molecular epidemiology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Gates Open Res. 2023 Sep 25. doi: 10.21956/gatesopenres.14925.r34921

Reviewer response for version 1

Gerardo Santos-Lopez 1

The manuscript presented by Toyama et al. provides a comprehensive analysis of the three waves of COVID-19 in Peru. It covers a wide range of topics, from fundamental data to spatial and temporal distribution analyses across regions and provinces. The document is well-crafted, offering detailed descriptions, thorough analysis, and robust statistical modeling of the data. I've noticed a few minor issues that can be easily resolved:

  • There is an issue with the description in Figure 2; it really refers to Figure 3.

  • On page 7, in the "Regional cluster analysis" section, it mentions "(Figure 4C and Figure 4D)," but it should refer to Figures 4E and 4F.

  • I recommend highlighting the highest mortality rates in Table 3, in line with what was mentioned in the results section regarding the "Variability of the mortality rate across regions by wave, age, and gender."

  • Please review the wording in the description of Figure 4. There appear to be errors related to sections A-F.

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Yes

Are the conclusions drawn adequately supported by the results?

Yes

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

Diagnosis and epidemiology of viral infections, viral pathogenesis and development of antivirals.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Availability Statement

    The data used in our study is open data curated by the Peruvian government and freely available from ( Table 1):

    The official administrative boundaries for Peru regions are owned by the Ministry of Environment and can be accessed through the website https://www.geogpsperu.com.


    Articles from Gates Open Research are provided here courtesy of Bill & Melinda Gates Foundation

    RESOURCES